Cell‐Selective Delivery of RIBOTACs via an Anti‐EGFR Nanobody for Pancreatic Cancer Treatment.
Saved in:
| Title: | Cell‐Selective Delivery of RIBOTACs via an Anti‐EGFR Nanobody for Pancreatic Cancer Treatment. |
|---|---|
| Authors: | Luo, Tianli1,2 (AUTHOR), Wang, Yijuan1 (AUTHOR), Chen, Dengwang3 (AUTHOR), Zhang, Yinghan1 (AUTHOR), Shuai, Yi1 (AUTHOR), Yao, Hualiang1 (AUTHOR), Jiang, Tao1 (AUTHOR), Jiang, Hang1 (AUTHOR), Zhong, Ming1 (AUTHOR), Wang, Xiangeng1 (AUTHOR), Wang, Ziwei1 (AUTHOR), Xu, Chenchen1 (AUTHOR), Goel, Ajay4 (AUTHOR), MA, Hoi Tang2,5 (AUTHOR), Gao, Feng6 (AUTHOR), Wang, Xin1,7,8 (AUTHOR) xinwang@cuhk.edu.hk |
| Source: | Advanced Science. Jul2026, p1. 12p. 7 Illustrations. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
